Lobbyists Score Big: $35 Billion Windfall

A person handing over a stack of cash to another individual in a suit — $35 BILLION BOMBSHELL

The Trump administration just handed private insurers a $35 billion windfall while taxpayers continue bleeding $84 billion annually in Medicare Advantage overpayments—a stunning victory for corporate lobbying over fiscal responsibility.

Story Snapshot

CMS finalized a 7.2% Medicare Advantage payment increase for 2026, adding $35 billion compared to 2025 and far exceeding January’s 4.3% projection
The payment boost arrives despite documented 20% overpayments to insurers totaling $84 billion in 2025, driven largely by questionable diagnosis coding practices
Thirty-five million Medicare Advantage enrollees face uncertain futures as 2027 proposals signal near-zero payment growth amid mounting fiscal pressure
Federal audits revealed $23.67 billion in improper Medicare Part C payments for fiscal 2025, with most traced to unsubstantiated diagnoses

The Payment Surprise That Shouldn’t Have Been a Surprise

CMS stunned health policy watchers on April 6, 2026, by finalizing Medicare Advantage rates at 7.2% growth—a far cry from the austere 4.3% floated in January. The additional $35 billion flows primarily from traditional Medicare spending surges of 9.0% and risk coding adjustments adding 2.1%, partially offset by risk model recalibrations.

Insurers covering 35 million seniors and disabled Americans had braced for tighter margins, but intensive lobbying and data submissions apparently moved the needle. The final number incorporates Biden-era reforms intended to curb overpayments while maintaining the gravy train for another year.

The US Medicare program will pay private insurers 2.48% more in 2027, a meaningful improvement over the initial rates the agency proposed in January https://t.co/ynS7Ip3kK0

— Bloomberg (@business) April 6, 2026

The Upcoding Machine Keeps Churning Billions

Medicare Advantage operates on a deceptively simple premise: private insurers receive capitated payments based on how sick their enrollees appear on paper. The sicker the documented diagnosis, the higher the payment. This creates perverse incentives for “upcoding”—aggressive documentation of conditions to inflate apparent health risks.

The Medicare Payment Advisory Commission pegs the resulting overpayments at 20% above traditional Medicare costs, draining $84 billion from taxpayers in 2025 alone. Federal audits confirm the problem runs deep, identifying a 6.0% improper payment rate totaling $23.67 billion in fiscal 2025, with unsubstantiated diagnoses driving most overcharges.

Historical Context Reveals a Predictable Pattern

The 2026 rate follows a rollercoaster of annual increases: 8.5% in 2023, 3.3% in 2024, and 3.7% in 2025. Each year, insurers lobby furiously while advocacy groups demand accountability for systematic overcharges.

The Biden administration attempted reforms through updated risk adjustment models and benchmark modifications, which Trump’s CMS has now phased in while simultaneously delivering the generous 2026 increase.

The contradictory signals—austerity rhetoric paired with lavish payouts—reveal an administration caught between fiscal hawks demanding cuts and industry titans wielding enormous lobbying power through groups like America’s Health Insurance Plans and the Better Medicare Alliance.

The Lobbying Blitz That Moved Mountains

Behind the 2026 windfall lies an unprecedented influence campaign. Insurers flooded CMS with record-breaking comment submissions on the proposed anemic 2027 rates, warning of catastrophic benefit cuts and network disruptions for vulnerable seniors.

The Better Medicare Alliance commissioned consultancy analyses projecting losses of twelve dollars per member monthly from modest payment tweaks. Stocks for giants like UnitedHealth Group and Humana tumbled on 2027 austerity signals, adding market pressure to policy debates.

Meanwhile, CMS finalized separate star ratings changes worth an additional $18.6 billion to insurers over a decade—more generous than proposed rules anticipated, delivering another $5.4 billion gift beyond expectations.

What This Means for Seniors and Taxpayers

The immediate impact splits along predictable lines. Thirty-five million Medicare Advantage enrollees enjoy stable 2026 benefits as insurers bank their payment boost, avoiding the benefit cuts and network narrowing threatened under tighter margins.

Taxpayers, however, continue funding an $84 billion annual overpayment while federal deficits balloon and entitlement programs face long-term solvency questions. The stark 2027 proposal at 0.09% growth looms ominously, suggesting the Trump administration may deliver delayed pain after the 2026 reprieve.

If implemented, seniors could face premium hikes, reduced supplemental benefits like dental and vision coverage, or restricted provider networks as insurers scramble to maintain profitability under flat payment growth.

Conflicting Visions for Medicare’s Privatized Future

Policy experts remain sharply divided on the path forward. Insurers and allied groups frame any payment constraints as threats to seniors’ access and choice, arguing that their risk-adjusted payments merely reflect actual costs of caring for complex populations.

The American Economic Liberties Project counters that flat or negative payment growth represents overdue correction of systematic fraud, urging aggressive cuts beyond current proposals. MedPAC data supports the reform camp, documenting how upcoding inflates payments without corresponding care improvements.

CMS officials acknowledge industry input but insist traditional Medicare spending trends and model integrity drive decisions—a claim undermined by the gap between January projections and April’s final generosity.

The 2026 Medicare Advantage payment story crystallizes a fundamental tension in American healthcare policy: corporate profits versus taxpayer protection, privatization versus traditional public insurance, lobbying influence versus fiscal discipline.

The Trump administration’s split decision—delivering 2026 riches while threatening 2027 austerity—postpones rather than resolves these contradictions. As improper payments exceed $23 billion annually and enrollment growth accelerates, the sustainability question grows more urgent.

Conservative principles of fiscal responsibility and opposition to crony capitalism demand scrutiny of an $84 billion overpayment scandal dressed up as senior care. Yet the political reality of 35 million enrolled voters and deep-pocketed industry lobbyists ensures Medicare Advantage remains untouchable, regardless of which party controls the White House or what the audits reveal.